Allergicheskiy kon\"yunktivit


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Article is devoted to the topical issue of clinical allergology - diagnosis and treatment of allergic conjunctivitis (AC). The article presents the data on the prevalence of AC, and discusses the classification, clinical manifestations of the disease. Methods of diagnosis and treatment of various forms of AC are represented in detail, the features of effects of locally acting antihistamines, including olopatadine hydrochloride 0.1% (Opatanol), are discussed.

Full Text

Restricted Access

About the authors

L. A Goryachkina

E. P Terekhova

References

  1. Клиническая аллергология: руководство для практикующих врачей / Под ред.Р.М. Хаитова. М., 2002. С. 191-206.
  2. Клиническая иммунология и аллергология/ Под ред. Г. Лолора-мл., Т. Фишера, Д. Адельмана М., 2000. С. 162-72.
  3. Курбачева О.М., Павлова К.С. Аллергический конъюнктивит: современный взгляд на актуальную проблему // Рос. аллергол. журнал 2011. № 1. С. 92-7.
  4. Леппенен Н.Э., Пампура А.Н. Аллергический конъюнктивит у детей: от патогенеза к терапии // Рос. аллергол. журнал 2012. № 1. С. 70-4.
  5. Майчук Д.Ю., Куренков В.В., Кашникова О.А. В кн. Актуальные вопросы воспалительных заболеваний глаз. М., 2001. С. 232-34.
  6. Майчук Ю.Ф. Вестник офтальмологии. М.: 2000. № 5. С. 10-14.
  7. Майчук Ю.Ф, Позднякова В.В., Якушина Л.Н. Опатанол (олопатадин гидрохлорид 0,1 %) в лечении аллергических заболеваний глаз // РМЖ2007. Т. 8. № 2. С. 63-7.
  8. МайчукЮ.Ф.,Ковалевская М.А,Бржеский В.В. и др. Синдром "красного глаза". Практическое руководство для врачей-офтальмологов. М., 2010. С. 82-3.
  9. Мачарадзе Д.Ш. Лечение аллергических конъюнктивитов // Лечащий врач 2008. № 4. С. 20-2.
  10. Патерсон Р., Грэммер Л.К., Гринберг П.А. Аллергические болезни: диагностика и лечение. Пер. с англ. / Под ред. А.Г. Чучалина, И.С. Гущина, Э.Г. Улумбекова, Р.С. Фасахова. М., 2000. С. 208-23.
  11. Aguilar AJ, et al. Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0,1 % olopatadine hydrochloride versus 0,0 5% ketotifen fumarate. Acta Ophthalmologica Scandinavica 2000;78:52-5.
  12. Artal MN, et al. A forced choice comfort study of olopatadine hydrochloride 0,1 % versus keto tifen fumarate 0,05 %o. Acta Ophthalmologica Scandinavica 2000;78:64-5.
  13. Berdy GJ, et al. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0,1 % ophthalmic solution and ketotifen fumarate 0,025 % ophthalmic solution in the conjunctival antigen challenge model. Clinical Therapeutics 2002;22(7):1-8.
  14. Berdy GJ, Stoppel JO, Epstein AB. Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0,1 % ophthalmic solution and loteprednol etabonate 0,2 % ophthalmic suspension in the conjunctival allergen challenge model. Clin Ther 2002;24(6): 918-29.
  15. Bielory L, Lien KW, Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs 2005;65(2):215-28.
  16. Bielory L, Katelaris C, Lightman S, Naclerio R. Treating the Ocular Component of Allergic Rhinoconjunctivitis and Related Eye Disorders. Med Gen Med 2007;9(3):35-9.
  17. Butrus, et al. Comparison of the Clinical Efficacy and Comfort of Olopatadine Hydrochloride 0,1 % Ophthalmic Solution and Nedocromil Sodium 2 % Ophthalmic Solution in the Human Conjunctival Allergen Challenge Model. Reprinted from Clinical Therapeutics. Excerpta Medica Inc 2000;22(12).
  18. Katelaris CH, Ciprandi G, Missotten L, et al. for the International Olopatadine Study Group. A comparison of the efficacy and tolerability of olopatadine hydrochloride 0,1 % ophthalmic solution and cromolyn sodium 2 % ophthalmic solution in seasonal allergic conjunctivitis. Clin Ther 2002;24 (10):1561-75.
  19. Lanier BQ, Gross RD, Marks BB, et al. Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms. Ann Allergy Asthma Immunol 2001;86:641-48.
  20. Leonardi A, Zafirakis P. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: A double-masked, environmental study of patient preference. Curr Med Res Opin 2004;20(8):1167-73.
  21. Mantelli F, Santos MS, Petitti T, et al. Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. Br J Ophthalmol 2007;91(12): 1656-61.
  22. Ono SJ, Abelson MB. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 2005;115:118-22.
  23. Rosenwasser LJ, O'Brien T, Weyne J. Mast cell stabilization and antihistamine effects of olopatadine ophthalmic solution: a review of preclinical and clinical research. Curr Med Res Opin 2005;21(9):1377-87.
  24. Spangler DL, Bensch G, Berdy GJ. Evaluation of the efficacy of olopatadine hydrochloride 0,1 % ophthalmic solution and azelastine hydrochloride 0,05 % ophthalmic solution in the conjunctival allergen challenge model. Clinical Therapeutics 2001;23:1272-80.
  25. Wuthrich B, Brignoli R, Canevascini M, et al. Epidemiological survey in hay fever patients: symptom prevalence and severity and influence on patient management. Schweiz Med Wochenschr 1998;128: 139-43.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies